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THE EFFECTS OF EXTRACELLULAR MATRIX ON BEIGE ADIPOGENESIS 
IN SUBCUTANEOUS FAT 
 
LI WAN 
 
ABSTRACT 
Adipose tissue is an organ that plays an important role in energy storage, 
nutritional balance and thermogenesis. White and brown adipose tissues have distinct cell 
morphology and metabolic functions. White adipose tissue (WAT) with unilocular lipid 
droplets serves as a major site of energy storage, while brown adipose tissue (BAT) with 
multilocular lipid droplets plays an important role in thermogenesis via a mitochondrial 
protein, uncoupling protein 1 (UCP1). These cells are derived from mesenchymal stem 
cells (MSCs). Newly discovered beige adipocytes are derived from the same MSC 
precursors as WAT but resemble BAT due to expression of UCP1. Due to side effects of 
drugs for treating obesity, activation of UCP1 positive beige adipocytes in WAT has 
become a new therapeutic target. The interaction of extracellular matrix (ECM) with 
integrin was found to regulate cell specification of mesenchymal stem cells (MSCs) via 
intracellular signaling. However, the role of individual ECM proteins in beige 
adipogenesis in WAT remains unknown. Therefore, we established a system for culturing 
stromal vascular fraction (SVF) cells from inguinal WAT on ECM protein coated plates 
and differentiating the cells into either white or beige adipocytes. We found that cells 
cultured on type I collagen had more round cell morphology and higher mRNA 
expression of thermogenic genes, UCP1 and type II iodothyronine deiodinase (DIO2), 
which was further enhanced in myocardin-related transcription factor A (MRTFA) 
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knockout SVF cells. MRTFA has been reported to regulate beige adipogenesis in BMP-
ROCK signaling pathway. Based on our data, we found that type I collagen-integrin 
signaling regulates beige adipogenesis by controlling the activity of MRTFA in MSCs. 
Our study has provided an insight into developing therapeutic drugs to enhance beige 
adipocytes formation in WAT for reducing obesity in the future.  
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INTRODUCTION 
 	   Adipose tissue is an organ that plays an important role in energy storage, 
nutritional balance and thermogenesis. There are two types of adipose tissues with 
distinct cell morphology and metabolic functions, called white and brown. In vivo, white 
adipocytes contain a large, unilocular lipid droplet that serves as the major site of 
triglyceride storage in the body, while brown adipocytes contain multiple, small 
multilocular lipid droplets. Additionally, brown adipocytes are characterized by large 
numbers of mitochondria that generate heat through uncoupled respiration via uncoupling 
protein 1 (UCP1) (Rosen and Spiegelman 2014).  
In response to excessive nutrition, white adipose tissue (WAT) expands through 
hypertrophy (an increase in cell size) and hyperplasia (an increase in cell number) (Sun, 
Kusminski, and Scherer 2011), causing greater adiposity and leading to obesity. 
According to CDC statistics data, prevalence of obesity exceeded more than one third of 
the U.S. population from 2011 to 2014. Beyond the high medical cost, obesity is 
associated with Type II diabetes, cardiovascular diseases and other metabolic disorders. 
The cause of obesity is associated with multiple factors, such as genetic predisposition, 
environment and nutritional status (Bays et al. 2013).  
Current therapeutic strategies for obesity include dietary intervention, physical 
activity, bariatric surgery and pharmaceutical medications, such as sibutramine for 
appetite suppression and orlistat for reducing dietary fat absorption (Wilborn et al. 2005). 
However, these drugs are associated with severe side effects. For example, orlistat was 
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found to cause gastrointestinal problems and liver damage, and sibutramine was 
associated with higher blood pressure and cardiovascular risks (Ioannides-Demos, 
Piccenna, and McNeil 2011).  
Recently, due to its thermogenic function, brown adipose tissue (BAT) has been 
investigated as a therapeutic target to reduce risk of obesity and metabolic disorders 
(Cypess and Kahn 2010).  BAT produces heat through UCP1 protein inside the 
mitochondrial inner membrane (MIM), which is activated through the sympathetic 
nervous system. Upon activation, protons produced by nutrient oxidation enter the MIM 
through the UCP1 protein channel to produce heat rather than through the ATP synthase 
that produces ATP (Argyropoulos and Harper 2002, Harms and Seale 2013). As activated 
BAT was reported to increase energy expenditure via UCP1 while reducing WAT via 
triglyceride breakdown (Saito 2013), enhancement of BAT activities could be a 
prospective strategy for combating obesity.  
BAT has been found to exist in adult humans, however, PET-CT scan has indicated 
that it is inversely correlated with age and body mass index (Cypess et al. 2009). In recent 
years, another type of adipocyte, referred to as beige, has been found in white adipose 
tissue and shown to resemble brown adipocytes by expressing UCP1 in response to either 
cold exposure or β-adrenergic stimuli (Vitali et al. 2012, Himms-Hagen et al. 2000). 
Recent evidence suggests that those beige adipocytes are most likely to develop from 
precursor cells in subcutaneous WAT (Wang et al. 2013).  
In obesity, pathogenic expansion of adipose tissue exceeds the oxygen supply limit 
that could lead to a hypoxic state and induce hypoxia-inducible factor 1 alpha (HIF1A); 
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HIF1A could stimulate inflammatory factors and recruit macrophage infiltration, 
eventually causing excessive synthesis and accumulation of extracellular cellular matrix 
(ECM) (Sun et al. 2013). The components of ECM surrounding adipocytes include 
laminin, fibronectin and collagen type I-VI, which are essential in ECM turnover during 
adipose tissue expansion (Mariman and Wang 2010). However, high density of ECM 
proteins, specifically collagen type I and fibronectin, was also found to increase 
inflammation and reduce insulin sensitivity in 3T3-L1 adipocytes (Li et al. 2010). Several 
studies have reported that ECM proteins are associated with adipocyte differentiation. 
One study has found that cellular fibronectin synthesis decreased during differentiation of 
3T3-F442A pre-adipocyte cell line (Antras et al. 1989). Another study cultured 3T3-
F442A cell line on fibronectin-coated plates and found that the cells have reduced lipid 
accumulation during adipocyte differentiation (Spiegelman and Ginty 1983).  
Beyond the role of ECM in maintaining cell structure, ECM also possesses an 
important function in interacting with stem cells that regulate the self-renewal and 
differentiation of the cells in different tissues (Gattazzo, Urciuolo, and Bonaldo 2014). 
ECM plasticity was previously shown to determine lineage specification and 
differentiation of mesenchymal stem cells (MSCs) such that stiff matrix drives osteogenic 
differentiation and soft matrix favors neuron formation (Engler et al. 2006). MSCs are a 
type of cells that have potential for differentiating into adipocytes in humans (Pittenger et 
al. 1999). One study found that increasing ECM engagement (collagen type IV) with 
cells through macromolecular crowding enhances UCP1 expression and brown 
adipogenesis in human bone marrow MSCs (Lee et al. 2016). 
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ECM interacts with stem cell through transmembrane receptors, integrins, which 
transduce signals from outside to inside of cells (Gattazzo, Urciuolo, and Bonaldo 2014,  
Legate, Wickström, and Fässler 2009). An integrin is composed of two subunits, α (18 
types) and β (8 types), and each subunit combination has different ligand binding 
affinities to different ECM proteins (Campbell and Humphries 2011), including 
fibronectin (e.g. α5β1, αVβ1), collagen (e.g. α1β1, α2β1 for Collagen I) and laminin (e.g. 
α1β1, α2β1, α3β1) (Hynes 1987, Johansson et al. 1997, Jokinen et al. 2004, Belkin and 
Stepp 2000). As signal transducer, integrins are able to regulate gene expression, cell 
growth and differentiation (Legate, Wickström, and Fässler 2009). During adipocyte 
differentiation, the expression of integrin α5 decreases in 3T3-L1 adipocyte cell line (Liu 
et al. 2005). During differentiation of human adipose tissue stem cells, expression of 
integrin αV and α5 have also been shown to be down regulated (Morandi et al. 2016).   
Recently the co-expression of αV and β1 integrin was found to induce expression of 
myocardin-related transcription factor A (MRTFA) and promote serum response factor 
(SRF) transcription (Hermann et al. 2016). The gene targets of MRTFA-SRF complex 
regulate cytoskeletal dynamics, cell movement, ECM synthesis, and skeletal muscle 
differentiation (Olson and Nordheim 2010, Esnault et al. 2014). Our lab has demonstrated 
that MRTFA, is a part of BMP7-ROCK signaling pathway that regulates beige adipocyte 
formation, and MRTFA knockout mice contained more beige adipocytes in inguinal 
WAT and are more metabolically healthy than wild type mice (McDonald et al. 2015). 
BMP7 is a member of bone morphogenetic proteins (BMPs) that were found to promote 
adipocyte differentiation of MSCs, and BMP7 particularly activates brown adipogenesis 
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(Jiramongkolchai, Owens, and Hong 2016, Tseng et al. 2008). ROCK, Rho-associated 
protein kinase, modulates conversion of G-actin to F-actin that facilitates entry of 
MRTFA into the nucleus to interact with SRF (Olson and Nordheim 2010), and it was 
found to be inhibited by BMP7 (McDonald et al. 2015). MRTFA was also suggested to 
determine the cell fate of mesenchymal stem cell by promoting osteogenesis rather than 
adipogenesis (Bian et al. 2016).  
These observations suggest that the ECM has a role in regulating beige adipogenesis 
of MSCs via integrin signaling, which maybe further regulated by MRTFA. Previous 
studies investigated the effects of ECM on stem cell lineage determination, but its role on 
beige adipogenesis still remains unclear. Therefore, in this study, we investigated the 
effects of different ECM proteins, integrin-binding peptide of fibronectin, RGDS (Arg-
Gly-Asp-Ser) peptide, collagen type I and type IV on beige adipogenesis in subcutaneous 
WAT of wild type (WT) and MRTFA knockout (MRTFA-/-) mice. We found that 
collagen type IV and RGDS do not affect adipogenic differentiation of MSCs in WT 
inguinal WAT (iWAT), but collagen type I enhances the thermogenic gene program and 
this enhancement is greater in MRTFA-/- mice compared to WT mice. We conclude that 
ECM-integrin signaling regulates beige adipogenesis by controlling the activity of 
MRTFA in MSCs. 
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METHODS  
 
Animals  
MRTFA-/- mice were obtained from Eric Olson UTSW. WT and MRTFA-/- 
C57BL/6 mice (6-12 weeks old) were fed with normal chow diet ad libitum and housed 
at 23°C in a 12h light/dark cycle. All animal studies were performed in accordance to 
Boston University School of Medicine Institutional Animal Care and Use Committee. 
ECM Protein Coating  
Stocks of collagen type I (rat tail), synthetic RGDS (Arg-Gly-Asp-Ser) peptide 
and collagen type IV (bovine) were diluted to 50 µg/ml with calcium and magnesium free 
phosphate buffered saline (PBS). The diluted proteins were added to evenly coat multi-
well cell culture plates: 300 µl per well for 24-well plate, 500 µl per well for 12-well 
plate, and 1000 µl per well for 6-well plate. Coated plates were incubated at room 
temperature for 2 hours, and rinsed with sterile distilled deionized water.  
Extraction of Stromal Vascular Fraction  
Inguinal fat pads were extracted from WT and MRTFA-/- mice. Minced fat pads 
were digested in Dulbecco’s Modified Eagle Medium (DMEM) with collagenase type I 
(0.02 g/10 ml), collagenase type II (0.01 g/10 ml), and bovine serum albumin (0.2 g/10 
ml), agitating at 37°C for 30 - 45 minutes. The fat pads in digestion solution were filtered 
through 40 μm nylon mesh, and digestion was stopped by adding DMEM with 10% fetal 
bovine serum (FBS) and penicillin-streptomycin (PS), and centrifuged at 500 g for 10 
minutes. 300 µL 10X Red blood cell lysis buffer (8.02 g ammonium chloride, 0.84 g 
sodium bicarbonate, and 0.37 g EDTA dissolved in 100 mL water) was added to the cell 
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pellet for 3 minutes. After 3 minutes, lysis was stopped by adding PBS, and centrifuged 
at 500 g for 10 minutes. Cell pellet was re-suspended in DMEM with PS and 10% FBS 
and added into cell culture plates.  
Cell Culture  
Cells were maintained in 10% FBS DMEM and incubated at 37°C with 5% CO2 
until reaching confluence. For adipocyte differentiation, the confluent cells were treated 
with differentiation cocktail DMI containing 5 µM dexamethasone, 0.5 mM 
isobutylmethylxanthine and 4 µg/ml insulin from day 0 to day 2, and were maintained 
with 4 µg/ml insulin from day 2 to day 8. For rosiglitazone treatment, the confluent cells 
were treated with differentiation cocktail DMI and 1 µg/ml rosiglitazone from day 0 to 
day 2, and were maintained with 4 µg/ml insulin from day 2 to day 8. For beige adipocyte 
differentiation, the confluent cells were treated with differentiation cocktail DMI, 1 nM 
3,3,5 –triiodo-L-thyronine (T3) and 125 µM indomethacin from day 0 to day 2, and were 
maintained with 4 µg/ml insulin and T3 from day 2 to day 8.  
Gene Expression Analysis  
Cells were washed with PBS and then lysed with 250 µL per well TRIzol reagent 
and transferred into sterile eppendorf tubes after mixing. After 5 minutes incubation at 
room temperature, 50 µL chloroform was added to each tube to separate the RNA 
containing aqueous layer and followed by 15 seconds shaking. After 3 minutes 
incubation at room temperature, tubes were centrifuged at 12000 g for 15 minutes at 4°C. 
The top aqueous layer was transferred into new eppendorf tubes. 125 µL isopropanol was 
added to each tube to precipitate RNA followed by centrifugation at 12000 g for 15 
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minutes at 4°C. The supernatant was removed and the RNA pellet was resuspended with 
250 µL 75% ethanol and centrifuged at 12000 g for 10 minutes at 4°C.  The supernatant 
was removed and the pellet was subsequently air dried.  
RNA concentration was measured using a NanoDrop Spectrophotometer. cDNA 
synthesis was performed by using purified RNA and Thermo Scientific Maxima First 
Strand cDNA Synthesis Kit (reaction buffer, dNTPs, oligonucleotides and random 
primer). The real-time reverse transcription polymerase chain reaction (RT-qPCR) was 
performed with diluted cDNA, Thermo Scientific Fast SYBRTM Green Master Mix and 5 
µM reverse and forward primers of each target gene (listed in table 1).  
 Forward Sequence Reverse Sequence  
PPARg GCATGGTGCCTTCGCTGA 
 
TGGCATCTCTGTGTCAACCATG 
 
CEBPa AAACAACGCAACGTGGAGA 
 
GCGGTCATTGTCACTGGTC 
 
FABP4 AAGGTGAAGAGCATCATAACCCT 
 
TCACGCCTTTCATAACACATTCC 
 
UCP1  AGGCTTCCAGTACCATTAGGT  CTGAGTGAGGCAAAGCTGATTT 
 
DIO2  AATTATGCCTCGGAGAAGACCG  
 
GGCAGTTGCCTAGTGAAAGGT 
 
FASN GCTGCGGAAACTTCAGGAAAT  
 
AGAGACGTGTCACTCCTGGACTT 
 
ADIPOQ GCACTGGCAAGTTCTACTGCAA 
 
GTAGGTGAAGAGAACGGCCTTGT 
 
Table 1.  Forward and reverse sequences of qPCR primers 
 
Protein Expression Analysis  
To extract the total proteins from the cells, 350 µL protein lysis buffer (100 mM 
Tris HCl, 2.5 mM EDTA, 0.45 % NP-40, 0.45 % Tween 20) with Thermo Scientific 
HaltTM phosphatase inhibitor single-use cocktail (100X) and HaltTM protease inhibitor 
cocktail (100X) was added to each well of cells. The plates were placed on a shaker at 
4°C for 15 minutes, and lysates were transferred into tubes. The tubes were centrifuged at 
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10000 g for 10 minutes, and the protein containing supernatant was collected and stored 
at -20°C. Protein concentration was measured using the bicinchoninic acid assay 
(Thermo Scientific PierceTM BCA Protein Assay Kit) following manufacturer’s 
instructions. 
Western blot was performed to measure expression level of each target protein 
(protocol from Abcam). 10 µg sample protein was mixed with 5 µL Thermo Scientific 
NuPAGETM LDS Sample Buffer (4X) and 2 µL 10X BoltTM Sample Reducing Agent. 
Protein solution was heated at 70°C for 10 minutes. 12% SDS-PAGE separating gel was 
made with 3.2 mL sterile distilled deionized water, 4 mL Acrylamide/Bis-acrylamide 
(30 %/0.8 % w/v), 2.6 mL 1.5M Tris (PH=8.8), 200 µL 10 % ammonium persulfate, 100 
µL 10 % SDS and 10 µL TEMED. The sample proteins and molecular weight marker 
were loaded into the gel. The gel was run for 90 minutes at 125 Volts. Then the proteins 
were transferred into nitrocellulose membrane using the Thermo Scientific iBlot 2 Dry 
Blotting System. The membrane was blocked for 1 hour in 5 % Dry Milk power 
dissolved in TTBS. The membrane was cut into pieces based on molecular weight of 
target proteins, and each membrane piece was incubated overnight in 1:1000 diluted 
primary antibodies (listed in table 2). After overnight incubation, the membranes were 
washed with TTBS and incubated with secondary antibody (rabbit) for 1 hour, followed 
by TTBS washing. 650 µL of each Thermo Scientific SuperSignalTM West Femto 
Maximum Sensitivity Substrate was added evenly to the membrane for chemiluminescent 
detection. The signals were detected by ChemiDocTM XRS+ System. 
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Primary Antibody  Manufacturer Catalog # 
α-Tubulin Cell Signaling 11H10 
FABP4 Cell Signaling D25B3 
Table 2. Primary antibodies of western blot 
 
Oil Red O Staining  
The cells were gently rinsed with calcium and magnesium free PBS, fixed with 
aqueous buffered zinc formalin and stored at 4°C overnight. Formalin was aspirated and 
distilled deionized water was gently added to rinse the plate. 60 % isopropanol was added 
to the plate, incubated at room temperature for 5 minutes, and aspirated. According to 
manufacturer’s instructions, Oil Red O stock solution was mixed with distilled deionized 
water by 3:2. The working solution was filtered and added to cells for 20 minutes with 
gentle agitation and then rinsed with sterile distilled deionized water until the water 
became clear. Photos were taken at 20X magnification through a phase contrast 
microscope.  
Statistical Analysis  
Two tailed student t-test was used to determine the statistical differences 
(significance: p≤0.05). Error bar represents standard error of mean. 	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RESULTS 
 
 
Mesenchymal Stem Cells (MSCs) Differentiate into Both White and Beige 
Adipocytes 
To establish a differentiation system, stromal vascular fraction (SVF) cells from 
inguinal white adipose tissue (iWAT) were maintained with DMEM  (CTR) or induced 
by adipocyte differentiation cocktails after reaching confluence: DMI (minimal white 
adipogenic cocktail), DMI+ROSI (white adipogenic cocktail) and DMI+T3+INDO 
(brown adipogenic cocktail). Some major cell types that adipose tissue SVF contain are 
pre-adipocytes, MSCs, T cells and endothelial precursor cells (Riordan et al. 2009).  
Compared to the cells at day 0 with long and fibroblast-like shape, the 
morphology of cells induced by differentiation cocktails gradually became more round 
and adipocyte-like at day 2, 4 and 8  (Figure 1.1). Lipid formation was observed and had 
the highest amount at day 8 (a lipid droplet was marked by black arrow), particularly in 
the cells induced by DMI+ROSI (Figure 1.1).  
To further confirm adipocyte differentiation through lipid droplet formation, the 
cells were fixed and stained with oil red o solution. Coincident with cell morphological 
changes, cells induced by differentiation cocktails had gradually increased lipid droplets 
from day 0 to day 8 (Figure 1.2). Although a few stained lipids were observed at day 2, 
they were more likely to be the lipids stored in fibroblasts than adipocytes (Figure 1.2). 
The cells at day 8 contained larger size and higher number of lipid droplets. Therefore, 
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oil red o staining provided further evidence for adipocyte formation from MSCs in iWAT 
(Figure 1.2).  
To analyze mRNA expression of adipocyte genes, RT-qPCR was performed. At 
day 4, mRNA expression of master adipogenic regulator gene, peroxisome proliferator-
activated receptor gamma (PPARg), in the cells induced by differentiation cocktails was 
significantly higher than CTR, and such significant differences were also observed at day 
8 (Figure 1.3). Another adipogenic gene, CCAAT/enhancer-binding protein alpha 
(CEBPa), increased gradually from day 0 to day 8 and had higher expression in induced 
cells than CTR, although no significant differences were detected (Figure 1.3).  
For lipogenesis gene, fatty acid binding protein 4 (FABP4), expressed 
significantly higher mRNA in induced cells than CTR at day 4 and 8, and significantly 
higher level in cells induced by DMI+T3+INDO than CTR at day 2 (Figure 1.3). For 
brown adipogenic genes, uncoupling protein 1 (UCP1), expressed significantly higher 
mRNA in cells induced by DMI+T3+INDO than CTR at day 2, 4 and 8 (Figure 1.3). 
Cells induced by DMI+T3+INDO had significantly higher mRNA of PR domain 
containing 16 (PRDM16) than CTR at day 8 (Figure 1.3).   
Overall, the data from cell morphology, oil red o staining and RT-qPCR 
suggested that DMI and DMI+ROSI cocktails induced MSCs into white adipocytes, and 
DMI+T3+INDO cocktail induced MSCs into beige adipocytes.  
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Figure 1.1 Morphological changes of SVF cells from iWAT  
Cells were maintained by DMEM (CTR) or induced by adipogenic differentiation 
cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 0, 2, 4, and 8, visualized under 
phase contrast microscopy.  
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Figure 1.2 Oil red o stained lipid droplets of SVF cells from iWAT 
Cells were maintained by DMEM (CTR) or induced by adipogenic differentiation 
cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 0, 2, 4, and 8, visualized under 
phase contrast microscopy.  
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Figure 1.3 Relative mRNA levels of adipogenic genes of SVF cells from iWAT 
Cells were maintained by DMEM (CTR) or induced by adipogenic differentiation 
cocktails:  DMI, DMI+ROSI and DMI+T3+INDO at day 0, 2, 4, and 8. Relative mRNA 
levels were determined by RT-qPCR. Data are presented as mean ± SEM, *p≤0.05, 
**p≤0.01, ***p≤0.001.  
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Collagen Type IV Does Not Affect Adipogenic Differentiation of MSCs  
After a differentiation system in iWAT SVF cells was established and 
effectiveness of the induction cocktails was examined, then the effects of collagen IV on 
both white and beige adipogenesis were investigated. At day 0, the cells were not 
differentiated and contained long and fibroblast-like morphology (Figure 2.1). At day 8, 
cells cultured on both none (NC) and Collagen IV (Col IV) coated plates and induced by 
cocktails showed a round cell shape and abundant lipid droplets (Figure 2.1). There was 
no obvious difference of cell shape and lipid amount of cells between NC and Col IV 
(Figure 2.1). 
Then mRNA expression of adipocyte genes was examined. As expected, cells on 
Col IV induced by differentiation cocktails expressed significantly higher level of 
common adipogenic genes, PPARg and CEBPa, than CTR at day 8 (Figure 2.2). For 
lipogenesis genes, FABP4 and Fatty Acid Synthase (FASN), were also higher in cells 
with cocktails than CTR on Col IV (Figure 2.2). For brown adipogenic genes, PRDM16 
showed a significantly higher expression level in cells induced by DMI+T3+INDO than 
CTR, and UCP1 expression had a trend (Figure 2.2). Except for cells induced by 
DMI+T3+INDO had significantly lower FABP4 level on Col IV than NC; overall, there 
was no significant difference of mRNA expression of all white and brown adipogenic 
genes between NC and Col IV in induced cells (Figure 2.2).  
Overall, the data from cell morphology and RT-qPCR suggested that collagen IV 
does not affect white and beige adipogenic differentiation of MSCs in iWAT.  
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Figure 2.1 Morphological changes of SVF cells on NC or Col IV plates 
Cells were cultured on NC or Col IV plates and maintained by DMEM (CTR) or induced 
by differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 0 and day 8, 
visualized under phase contrast microscopy.  
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Figure 2.2 Relative mRNA levels of adipogenic genes of SVF cells on NC or Col IV 
plates 
Cells were cultured on NC or Col IV plates and maintained by DMEM (CTR) or induced 
with DMI, DMI+ROSI and DMI+T3+INDO at day 0 and 8. Relative mRNA levels were 
determined by RT-qPCR. Data are presented as mean ± SEM, *p≤0.05.  
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Collagen Type I Not RGDS Enhanced Thermogenic Gene Expression of MSCs  
 To examine the effects of collagen Type I (Col I) and integrin binding peptide of 
fibronectin, RGDS, on adipogenic differentiation of MSCs, iWAT SVF cells were 
induced with differentiation cocktails for 8 days and cultured on plates coated with either 
Col I or RGDS. At day 0, there was no difference of cell morphology between NC, Col I 
and RGDS; few lipid droplets were observed in induced cells at day 2 (Figure 3.1). Lipid 
droplet formation was examined by staining the cells with oil red o solution. At day 0, in 
all groups, cells were stained with small amount of oil red o, and such lipids were more 
likely from fibroblasts. At day 2, the difference of lipid droplets in induced cells among 
each coating was not obvious (Figure 3.2). Interestingly, cells on Col presented a more 
adipocyte-like shape (Figure 3.2). Compared to cells on NC, mRNA expression of 
PPARg, CEBPa, FABP4 and FASN was slightly repressed by RGDS but enhanced by 
Col I in cells induced by DMI+T3+INDO, but the differences were not significant 
(Figure 3.3).  For brown fat specific genes, PRDM16 and UCP1 had significantly higher 
mRNA expression in cells induced by DMI+T3+INDO on Col I than NC, but there was 
no significant difference between RGDS and NC (Figure 3.3).  
The effects of RGDS and Col I on adipogenesis in later differentiation stage at 
day 8 were investigated. Cells with induction cocktails on Col I had more adipocyte-like 
cell shape and contained more lipid droplets than NC and RGDS, but there was no 
apparent difference between NC and RGDS (Figure 3.4).  Lipid formation was also 
examined by oil red o staining. Consistent with cell morphology, induced cells on Col I 
coated plates showed a more adipocyte-like cell shape and also contained larger and 
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higher amount of lipid droplets than NC and RGDS (Figure 3.5). There was no obvious 
difference between NC and RGDS in lipid droplet formation. Cells with differentiation 
cocktails did not have obvious differences of PPARg, CEBPa, FABP4 and FASN mRNA 
expression between NC and RGDS (Figure 3.6). The mRNA expression of UCP1 and 
PRDMI16 were slightly lower in cells induced by DMI+T3+INDO on RGDS than NC, 
but the differences were not significant (Figure 3.6). Cells induced by DMI+T3+INDO 
had significantly higher UCP1 mRNA expression level on Col than NC (Figure 3.6).  
Overall, the data from cell morphology, oil red o staining and RT-qPCR 
suggested that RGDS does not have an effect on adipogenesis, but collagen I enhances 
mRNA expression of brown fat gene of MSCs in iWAT.  
 
 
Figure 3.1 Morphological changes of SVF cells on NC, RGDS or Col I plates at day 
0 and 2 
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced by differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 0 and 
2, visualized under phase contrast microscopy.  
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Figure 3.2 Oil red o stained lipid droplets of SVF cells on NC, RGDS or Col I plates 
at day 0 and 2 
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced by differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 0 and 
2, visualized under phase contrast microscopy.  
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Figure 3.3 Relative mRNA levels of adipogenic genes of SVF cells on NC, RGDS or 
Col I plates at day 0 and 2 
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced with DMI, DMI+ROSI and DMI+T3+INDO at day 0 and 2. Relative mRNA 
levels were determined by RT-qPCR. Data are presented as mean ± SEM, *p≤0.05.  
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Figure 3.4 Morphological changes of SVF cells on NC, RGDS or Col I plates at day 
8 
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced by differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 8, 
visualized under phase contrast microscopy.  
 
 
 
Figure 3.5 Oil red o stained lipid droplets of SVF cells on NC, RGDS or Col I plates 
at day 8  
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced by differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 8, 
visualized under phase contrast microscopy.  
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Figure 3.6 Relative mRNA levels of adipogenic genes of SVF cells on NC, RGDS or 
Col I plates at day 8 
Cells were cultured on NC, RGDS or Col I plates and maintained by DMEM (CTR) or 
induced with DMI, DMI+ROSI and DMI+T3+INDO at day 8. Relative mRNA levels 
were determined by RT-qPCR. Data are presented as mean ± SEM, *p≤0.05.  
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Collagen Type I Enhanced Thermogenic Gene Expression of MSCs in MRTFA-/- 
Mice Compared to WT  
To examine the effects of collagen type I on adipogenesis of MSCs from 
MRTFA-/- mice, inguinal SVF cells from both WT and MTRFA-/- mice were cultured 
on collagen type I coated plates until reaching confluence, and then induced by 
differentiation cocktails for 8 days. From day 0 to day 6, small lipid droplets began to 
develop in the induced cells, but there was obvious difference between WT and MRTFA-
/- cells cultured on Col I plates (Figure 4.1, 4.2, 4.3). At day 8, a large amount of lipid 
droplets and adipocyte-like cells were observed in the induced cells; cells induced by 
DMI+T3+INDO on Col I plates contained less lipid droplets than NC from MRTFA-/- 
mice (Figure 4.4). Lipid formation was further examined by oil red o staining. No 
staining was observed at day 0 and all CTR groups at day 8, and cells with differentiation 
cocktails contained oil red o positive cells, but the differences among groups were not 
obvious (Figure 4.5, 4.6).  
Based on mRNA expression analysis, DMI+ROSI and DMI+T3+INDO induced 
cells on Col I had significantly lower mRNA expression of PPARg and FABP4 than NC 
in MRTFA-/- mice (Figure 4.7). Adipocyte hormone marker gene, adiponectin 
(ADIPOQ), showed a similar trend as those two genes, but significant difference was 
only found in cells induced by DMI+ROSI (Figure 4.7). For brown fat specific gene, 
type II iodothyronine deiodinase (DIO2) expressed about 12 folds significantly higher in 
cells on Col I than NC induced by DMI+T3+INDO in MRTFA-/- mice (Figure 4.7). 
Cells on Col I induced by DMI+T3+INDO expressed 10 folds significantly higher DIO2 
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from MRTFA-/- than WT mice (Figure 4.7). The trend of UCP1 expression was similar 
as DIO2, but no significant difference was found (Figure 4.7).  
Protein expression of FABP4 at day 8 was also examined by western blot. Cells 
induced by DMI+ROSI and DMI+T3+INDO had more intense bands than CTR (Figure 
4.8). Cells induced by DMI+ROSI had slightly more intense bands in MRTFA-/- than 
WT mice, but the difference between NC and Col was not obvious (Figure 4.8). There 
was also no difference of band intensity in cells induced by DMI+T3+INDO between NC 
and Col in MRTFA-/- mice (Figure 4.8).  
Overall, the data from cell morphology, oil red o staining and RT-qPCR 
suggested that type I collagen enhances mRNA expression of brown genes, particularly 
in SVF cells lacking MRTFA.  
 
 
 
 
 
 
 
	  27 
	  	  	  	  	  	    
Figure 4.1 Morphological changes of SVF cells from WT or MRTFA-/- on NC or 
Col I plates at day 0 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) at day 0 and 2, visualized under phase 
contrast microscopy.  
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Figure 4.2 Morphological changes of SVF cells from WT or MRTFA-/- on NC or 
Col I plates at day 4 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) or induced by differentiation cocktails: 
DMI, DMI+ROSI and DMI+T3+INDO at day 4, visualized under phase contrast 
microscopy. 
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Figure 4.3 Morphological changes of SVF cells from WT or MRTFA-/- on NC or 
Col I plates at day 6 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) or induced by differentiation cocktails: 
DMI, DMI+ROSI and DMI+T3+INDO at day 6, visualized under phase contrast 
microscopy.  
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Figure 4.4 Morphological changes of SVF cells from WT or MRTFA-/- on NC or 
Col I plates at day 8 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) or induced by differentiation cocktails: 
DMI, DMI+ROSI and DMI+T3+INDO at day 8, visualized under phase contrast 
microscopy. 
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Figure 4.5 Oil red o stained lipid droplets stained of SVF cells from WT or MRTFA-
/-mice on NC or Col I plates at day 0 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) at day 0, visualized under phase contrast 
microscopy. 
 
 
 
Figure 4.6 Oil red o stained lipid droplets stained of SVF cells from WT or MRTFA-
/-mice on NC or Col I plates at day 8 
Cells from wild-type (WT) or MRFTA knockout (MRTFA-/-) mice were cultured on NC 
or Col I plates and maintained by DMEM (CTR) or induced by differentiation cocktails: 
DMI, DMI+ROSI and DMI+T3+INDO at day 8, visualized under phase contrast 
microscopy. 
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Figure 4.7 Relative mRNA levels of adipogenic genes of SVF cells from WT or 
MRTFA-/- mice on NC or Col I plates  
Cells from WT or MRTFA-/- mice that were cultured on NC or Col I coated plate and 
maintained by DMEM (CTR) or induced by differentiation cocktails: DMI, DMI+ROSI 
and DMI+T3+INDO at day 0 and day 8. Relative mRNA levels were determined by RT-
qPCR. Data are presented as mean ± SEM, *p≤0.05, **p≤0.01,  ***p≤0.001, 
0"
10"
20"
30"
40"
50"
60"
NC"" Col"I" NC"" Col"I"
**
*
PPARg
m
R
N
A 
ex
pr
es
si
on
 (f
ol
d 
ch
an
ge
) 
WT  KO
D8 CTR
D8 DMI
D8 DMI+ROSI
D8 DMI+INDO+T3
D0 CTR
m
R
N
A 
ex
pr
es
si
on
 (f
ol
d 
ch
an
ge
) 
0"
10"
20"
30"
40"
50"
60"
70"
80"
90"
NC"" Col"I" NC"" Col"I"
FABP4
**
**
WT  KO
0"
50"
100"
150"
200"
250"
NC"" Col"I"" NC"" Col"I"
ADIPOQ
m
R
N
A 
ex
pr
es
si
on
 (f
ol
d 
ch
an
ge
) 
WT  KO
*
0"
2"
4"
6"
8"
10"
12"
14"
16"
18"
20"
NC"" Col"I" NC"" Col"I"
UCP1
m
R
N
A 
ex
pr
es
si
on
 (f
ol
d 
ch
an
ge
) 
WT  KO
	  33 
 
 
 
Figure 4.8 FABP4 protein expression of SVF cells from WT or MRTFA-/- mice on 
NC or Col I plates at day 8 
FABP4 protein expression of iWAT SVF cells from WT and MRTFA-/- mice that were 
cultured on NC or Col I coated plate and maintained by DMEM (CTR) or induced by 
differentiation cocktails: DMI, DMI+ROSI and DMI+T3+INDO at day 8, analyzed by 
Western blot.  
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DISCUSSION 
 
Since current drugs for treating obesity have been reported to have severe side 
effects, such as gastrointestinal problems and cardiovascular risks (Ioannides-Demos, 
Piccenna, and McNeil 2011), it is important to research on alternative and new strategies 
to combat obesity. Enhancing BAT activity that increases thermogenesis and energy 
expenditure has been regarded as potential strategy for reducing obesity (Cypess and 
Kahn 2010). However, BAT decreases with age in humans, so increasing beige adipocyte 
formation and activity in WAT can be a prospective target to treat obesity. In this study, 
we researched the effects of extracellular matrix proteins on beige adipogenesis in 
inguinal WAT. We found that collagen type I regulated beige fat gene program via 
transcription factor MRTFA by enhancing mRNA expression of thermogenic genes 
during adipogenic differentiation of MSCs.  
 We have established an effective differentiation system in primary iWAT 
SVF cells. DMI and DMI+ROSI cocktails could induce MSCs into white adipocytes, 
while DMI+INDO+T3 cocktail could induce MSCs into beige adipocytes. The change of 
cell shape was observed from undifferentiated fibroblasts (long and spread) to 
differentiated adipocytes (round and clustered). Noticeably, cell morphology was similar 
between white and beige adipocytes. As is known, in vivo, white adipocytes are 
unilocular and brown adipocytes are multilocular. There are two possible reasons that 
multilocular lipid droplets are found in white adipocytes in our study. At first, in vitro 
study, a relatively long differentiation time period might be required to induce 
multilocular white adipocyte into unilocular. An in vitro study induced human MSCs by 
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DMI for 21 days, and the differentiated white adipocytes were found to be multilocular 
rather than unilocular (Ghoniem et al. 2015). Secondly, actin cytoskeleton status that is 
regulated by ECM-integrin interaction might be involved in prevention of single lipid 
droplet formation. One study found that enhancing actin depolymerization in 
macrophages by using cytochalasin D led to a decrease in cholesteryl ester synthesis and 
lipid droplet size (Weibel et al. 2012). In future studies, to improve the effectiveness of 
white adipogenic cocktail and promote large single lipid droplet formation, higher dose 
of insulin could be used, as insulin has been reported to inhibit lipolysis and enhance 
triglyceride storage (Chakrabarti et al. 2013).  
 Among different types of adipose ECM proteins, we first studied collagen 
type IV which is a basement membrane protein that interacts with α1β1 and α2β1 integrin 
and other non-integrin receptors (Khoshnoodi, Pedchenko, and Hudson 2008). In our 
study, we found that collagen IV has no effect on adipogenic differentiation of MSCs. 
There is no difference of cell morphology between non-coating and collagen IV coating. 
Cell shape was previously shown to play an important role in regulating human MSCs 
commitment either into adipocytes or osteoblasts via a GTPase protein called RhoA 
(McBeath et al. 2004). More specifically, flatten and spread cell shape increases RhoA 
activity to interact with ROCK that enhances actin cytoskeleton tension to favor 
osteogenic over adipogenic differentiation (McBeath et al. 2004). Therefore, it suggests 
that the interaction of collagen IV with its corresponding cell surface receptors might not 
affect cell anchorage and spreading, leading to no change in RhoA-ROCK signaling 
pathway, actin cytoskeleton and adipogenesis. The reason that collagen IV does not affect 
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MSCs commitment might be due to its interaction not only with integrin receptors but 
also with other non-integrin receptors, such as glycoprotein VI and mannose receptors 
(Khoshnoodi, Pedchenko, and Hudson 2008). It is possible that collagen IV interacts with 
those non-integrin receptors that trigger other signaling pathways rather than RhoA-
ROCK. In addition, collagen IV might not have a role in regulating obesity, as it has been 
reported to present less amount in fibrotic adipose tissues as compared to other types of 
collagen and were not altered in obese adipose tissue (Spencer et al. 2011).  
 To further examine the effects of other types of ECM proteins, we focused 
on RGDS peptide, the binding sequence of fibronectin to integrin. RGDS was previously 
shown to interact with α5β1 and αVβ3 integrin (Basani et al. 2001). Integrin αV and β1 
subunits were found to promote MRTFA and SRF (Hermann et al. 2016), and MRTFA is 
a major negative regulator of beige adipocyte formation in WAT (McDonald et al. 2015). 
Moreover, previous studies have reported that adipogenesis of 3T3 cell line was 
associated with reduced synthesis of fibronectin, and fibronectin coating also reduced 
lipid accumulation during 3T3 cell differentiation (Antras et al. 1989, Spiegelman and 
Ginty 1983). 
 Therefore, as an integrin binding peptide of fibronectin, we hypothesized that 
RGDS would have an inhibitory effect on beige adipogenesis. However, unexpectedly in 
our study, RGDS did not significantly reduce mRNA expression of common adipogenic 
and thermogenic genes. It seems that our study is not coincident with previous studies 
working on fibronectin, but the difference of molecular size and receptor binding 
between RGDS and fibronectin could explain such inconsistency. Fibronectin is a larger 
	  37 
molecule than RGDS and can bind to non-integrin cell surface receptors as well as 
approximately 11 types of integrin receptors (Leiss et al. 2008).  
 The interaction of ECM proteins with integrin is important for cell adherence 
to surrounding environment and cell spreading. The density of integrin ligands plays a 
critical role in mediating cell spreading and focal adhesion complex formation 
(Cavalcanti-Adam et al. 2007). Cell cytoskeleton as part of focal adhesion is also 
involved in cell spreading, as actin polymerization was found to be required in the 
process of cell spreading over substrate (McGrath 2007). Thus, a stronger interaction of 
fibronectin to integrin than RGDS can lead to a more stable attachment of cells to ECM, 
then more flatten and spreading cell shape. As spreading cell shape favors osteogenesis 
over adipogenesis in human MSCs (McBeath et al. 2004), it is reasonable that the 
inhibitory effect of RGDS on adipogenesis becomes less obvious than fibronectin.   
 Then we studied the effects of collagen Type I on adipogenic differentiation 
of MSCs. In WT mice, we found that collagen I modified cells into round shape even in 
early stage of differentiation and enhanced mRNA expression of UCP1 during beige 
adipogenic differentiation. There is a possibility that collagen I-mediated cell rounding 
reduces RhoA-ROCK signaling and then inhibits MRTFA translocation into nucleus, 
enhancing beiging. This hypothesis has been further evidenced in MRTFA-/- mice model. 
Compared to WT mice, differentiated MSCs from MRTFA-/- mice have significantly 
higher mRNA expression of thermogenic gene DIO2, which is an important gene for 
BAT thermogenesis (de Jesus et al. 2001). Another BAT thermogenic gene, UCP1, 
shared same trend although no significance was detected. Our lab previously identified 
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MRTFA as a major regulator of beige adipocyte formation in BMP7-ROCK signaling 
pathway (McDonald et al. 2015), so our findings further suggests that collagen type I 
signaling regulates beige gene program by modulating MRTFA activity.  
 However, we cannot exclude a possibility that collagen I indirectly enhances 
cyclic AMP (cAMP) pathway that activates PGC-1a which further induces expression of 
thermogenic genes, such UCP1 and DIO2 (Harms and Seale 2013, Seale et al. 2007). In 
addition, PKA activated by cAMP was reported to suppress Rho kinase activity (Petersen 
et al. 2008). Whether collagen I enhances thermogenic program through cAMP signaling 
pathway, the details should be further investigated in future studies. Interestingly, in both 
wild type and MRTFA-/- MSCs, collagen I reduced common adipogenic genes during 
adipogenic differentiation. In a previous study, a transcriptional regulator, Zfp423, was 
found to inhibit brown genes (Ebf2 and Prdm16) to maintain white adipocyte 
characteristics in WAT (Shao et al. 2016). Therefore, it is possible that cells suppress 
white adipogenesis in order to enhance its brown gene program.    
 Taken together, our studies have identified a role of collagen type I in 
enhancing beige gene program in subcutaneous WAT, which is further controlled by 
MRTFA, a regulator of actin cytoskeleton. We suggest that the interaction of ECM 
proteins with integrin regulates adipogenesis through RhoA-ROCK-MRTFA pathway. 
Identification of MRTFA as a regulator of beige gene program in ECM-Integrin signaling 
provides a better understanding of the relationship between ECM and beige adipogenesis. 
Our study also provides an insight into developing potential therapeutic drugs for 
combating for obesity in the future.  
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